
Syngene and John Hopkins University to advance drug discovery
Syngene International has announced a strategic collaboration with John Hopkins University to advance early-stage drug discovery programmes. The collaboration will incorporate Syngene’s SynVent, a fully integrated drug discovery and development platform that spans discovery biology, medicinal and synthetic chemistry, DMPK (Drug Metabolism and Pharmacokinetics), toxicology, and early development. Syngene also intends to use its… Read More
